nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—migraine—Acetylsalicylic acid—coronary artery disease	0.47	1	CpDpCtD
Rizatriptan—HTR1B—Penbutolol—coronary artery disease	0.114	0.441	CbGbCtD
Rizatriptan—HTR1A—Penbutolol—coronary artery disease	0.0711	0.276	CbGbCtD
Rizatriptan—CYP1A2—Gemfibrozil—coronary artery disease	0.0317	0.123	CbGbCtD
Rizatriptan—CYP1A2—Clopidogrel—coronary artery disease	0.0275	0.107	CbGbCtD
Rizatriptan—CYP1A2—Losartan—coronary artery disease	0.0134	0.0521	CbGbCtD
Rizatriptan—Melatonin—CALR—coronary artery disease	0.00182	0.611	CrCbGaD
Rizatriptan—Melatonin—MPO—coronary artery disease	0.000357	0.12	CrCbGaD
Rizatriptan—Almotriptan—CYP2C19—coronary artery disease	0.000318	0.107	CrCbGaD
Rizatriptan—Melatonin—ESR1—coronary artery disease	0.000268	0.09	CrCbGaD
Rizatriptan—Melatonin—CYP2C19—coronary artery disease	0.000215	0.0722	CrCbGaD
Rizatriptan—Angioedema—Lisinopril—coronary artery disease	6.06e-05	0.000338	CcSEcCtD
Rizatriptan—Pruritus—Olmesartan—coronary artery disease	6.05e-05	0.000338	CcSEcCtD
Rizatriptan—Decreased appetite—Losartan—coronary artery disease	6.05e-05	0.000337	CcSEcCtD
Rizatriptan—Abdominal pain—Captopril—coronary artery disease	6.04e-05	0.000337	CcSEcCtD
Rizatriptan—Body temperature increased—Captopril—coronary artery disease	6.04e-05	0.000337	CcSEcCtD
Rizatriptan—Dizziness—Simvastatin—coronary artery disease	6.02e-05	0.000336	CcSEcCtD
Rizatriptan—Rash—Ezetimibe—coronary artery disease	6.02e-05	0.000336	CcSEcCtD
Rizatriptan—Dermatitis—Ezetimibe—coronary artery disease	6.02e-05	0.000335	CcSEcCtD
Rizatriptan—Confusional state—Ramipril—coronary artery disease	6.01e-05	0.000335	CcSEcCtD
Rizatriptan—Discomfort—Timolol—coronary artery disease	6.01e-05	0.000335	CcSEcCtD
Rizatriptan—Asthenia—Niacin—coronary artery disease	6e-05	0.000334	CcSEcCtD
Rizatriptan—Fatigue—Losartan—coronary artery disease	6e-05	0.000334	CcSEcCtD
Rizatriptan—Headache—Ezetimibe—coronary artery disease	5.98e-05	0.000334	CcSEcCtD
Rizatriptan—Anaphylactic shock—Ramipril—coronary artery disease	5.96e-05	0.000333	CcSEcCtD
Rizatriptan—Oedema—Ramipril—coronary artery disease	5.96e-05	0.000333	CcSEcCtD
Rizatriptan—Vertigo—Lisinopril—coronary artery disease	5.95e-05	0.000332	CcSEcCtD
Rizatriptan—Dry mouth—Timolol—coronary artery disease	5.95e-05	0.000332	CcSEcCtD
Rizatriptan—Pain—Losartan—coronary artery disease	5.95e-05	0.000332	CcSEcCtD
Rizatriptan—Constipation—Losartan—coronary artery disease	5.95e-05	0.000332	CcSEcCtD
Rizatriptan—Syncope—Lisinopril—coronary artery disease	5.94e-05	0.000331	CcSEcCtD
Rizatriptan—Vomiting—Eplerenone—coronary artery disease	5.94e-05	0.000331	CcSEcCtD
Rizatriptan—Feeling abnormal—Furosemide—coronary artery disease	5.94e-05	0.000331	CcSEcCtD
Rizatriptan—Nausea—Fenofibrate—coronary artery disease	5.92e-05	0.00033	CcSEcCtD
Rizatriptan—Pruritus—Niacin—coronary artery disease	5.92e-05	0.00033	CcSEcCtD
Rizatriptan—Asthenia—Pravastatin—coronary artery disease	5.91e-05	0.000329	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Furosemide—coronary artery disease	5.89e-05	0.000329	CcSEcCtD
Rizatriptan—Rash—Eplerenone—coronary artery disease	5.89e-05	0.000329	CcSEcCtD
Rizatriptan—Urticaria—Perindopril—coronary artery disease	5.89e-05	0.000328	CcSEcCtD
Rizatriptan—Hypersensitivity—Trandolapril—coronary artery disease	5.89e-05	0.000328	CcSEcCtD
Rizatriptan—Dermatitis—Eplerenone—coronary artery disease	5.89e-05	0.000328	CcSEcCtD
Rizatriptan—Diarrhoea—Valsartan—coronary artery disease	5.88e-05	0.000328	CcSEcCtD
Rizatriptan—Confusional state—Timolol—coronary artery disease	5.88e-05	0.000328	CcSEcCtD
Rizatriptan—Shock—Ramipril—coronary artery disease	5.87e-05	0.000327	CcSEcCtD
Rizatriptan—Hypersensitivity—Enalapril—coronary artery disease	5.87e-05	0.000327	CcSEcCtD
Rizatriptan—Abdominal pain—Perindopril—coronary artery disease	5.86e-05	0.000327	CcSEcCtD
Rizatriptan—Body temperature increased—Perindopril—coronary artery disease	5.86e-05	0.000327	CcSEcCtD
Rizatriptan—Palpitations—Lisinopril—coronary artery disease	5.86e-05	0.000327	CcSEcCtD
Rizatriptan—Diarrhoea—Olmesartan—coronary artery disease	5.86e-05	0.000326	CcSEcCtD
Rizatriptan—Headache—Eplerenone—coronary artery disease	5.86e-05	0.000326	CcSEcCtD
Rizatriptan—Nervous system disorder—Ramipril—coronary artery disease	5.85e-05	0.000326	CcSEcCtD
Rizatriptan—Oedema—Timolol—coronary artery disease	5.83e-05	0.000325	CcSEcCtD
Rizatriptan—Anaphylactic shock—Timolol—coronary artery disease	5.83e-05	0.000325	CcSEcCtD
Rizatriptan—Pruritus—Pravastatin—coronary artery disease	5.82e-05	0.000325	CcSEcCtD
Rizatriptan—Loss of consciousness—Lisinopril—coronary artery disease	5.82e-05	0.000325	CcSEcCtD
Rizatriptan—Nausea—Clopidogrel—coronary artery disease	5.82e-05	0.000325	CcSEcCtD
Rizatriptan—Tachycardia—Ramipril—coronary artery disease	5.82e-05	0.000325	CcSEcCtD
Rizatriptan—Vomiting—Simvastatin—coronary artery disease	5.79e-05	0.000323	CcSEcCtD
Rizatriptan—Hypersensitivity—Telmisartan—coronary artery disease	5.79e-05	0.000323	CcSEcCtD
Rizatriptan—Cough—Lisinopril—coronary artery disease	5.78e-05	0.000322	CcSEcCtD
Rizatriptan—Nausea—Lovastatin—coronary artery disease	5.78e-05	0.000322	CcSEcCtD
Rizatriptan—Hyperhidrosis—Ramipril—coronary artery disease	5.77e-05	0.000321	CcSEcCtD
Rizatriptan—Rash—Simvastatin—coronary artery disease	5.74e-05	0.00032	CcSEcCtD
Rizatriptan—Dermatitis—Simvastatin—coronary artery disease	5.74e-05	0.00032	CcSEcCtD
Rizatriptan—Asthenia—Trandolapril—coronary artery disease	5.74e-05	0.00032	CcSEcCtD
Rizatriptan—Shock—Timolol—coronary artery disease	5.74e-05	0.00032	CcSEcCtD
Rizatriptan—Feeling abnormal—Losartan—coronary artery disease	5.73e-05	0.00032	CcSEcCtD
Rizatriptan—Urticaria—Furosemide—coronary artery disease	5.73e-05	0.000319	CcSEcCtD
Rizatriptan—Diarrhoea—Niacin—coronary artery disease	5.72e-05	0.000319	CcSEcCtD
Rizatriptan—Nervous system disorder—Timolol—coronary artery disease	5.72e-05	0.000319	CcSEcCtD
Rizatriptan—Asthenia—Enalapril—coronary artery disease	5.71e-05	0.000319	CcSEcCtD
Rizatriptan—Headache—Simvastatin—coronary artery disease	5.7e-05	0.000318	CcSEcCtD
Rizatriptan—Abdominal pain—Furosemide—coronary artery disease	5.7e-05	0.000318	CcSEcCtD
Rizatriptan—Body temperature increased—Furosemide—coronary artery disease	5.7e-05	0.000318	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Losartan—coronary artery disease	5.69e-05	0.000317	CcSEcCtD
Rizatriptan—Dizziness—Valsartan—coronary artery disease	5.69e-05	0.000317	CcSEcCtD
Rizatriptan—Anorexia—Ramipril—coronary artery disease	5.68e-05	0.000317	CcSEcCtD
Rizatriptan—Nausea—Ezetimibe—coronary artery disease	5.67e-05	0.000316	CcSEcCtD
Rizatriptan—Dizziness—Olmesartan—coronary artery disease	5.66e-05	0.000316	CcSEcCtD
Rizatriptan—Pruritus—Trandolapril—coronary artery disease	5.66e-05	0.000315	CcSEcCtD
Rizatriptan—Myalgia—Lisinopril—coronary artery disease	5.64e-05	0.000315	CcSEcCtD
Rizatriptan—Arthralgia—Lisinopril—coronary artery disease	5.64e-05	0.000315	CcSEcCtD
Rizatriptan—Chest pain—Lisinopril—coronary artery disease	5.64e-05	0.000315	CcSEcCtD
Rizatriptan—Hyperhidrosis—Timolol—coronary artery disease	5.64e-05	0.000314	CcSEcCtD
Rizatriptan—Asthenia—Telmisartan—coronary artery disease	5.64e-05	0.000314	CcSEcCtD
Rizatriptan—Pruritus—Enalapril—coronary artery disease	5.63e-05	0.000314	CcSEcCtD
Rizatriptan—Diarrhoea—Pravastatin—coronary artery disease	5.63e-05	0.000314	CcSEcCtD
Rizatriptan—Anxiety—Lisinopril—coronary artery disease	5.62e-05	0.000313	CcSEcCtD
Rizatriptan—Discomfort—Lisinopril—coronary artery disease	5.57e-05	0.000311	CcSEcCtD
Rizatriptan—Anorexia—Timolol—coronary artery disease	5.56e-05	0.00031	CcSEcCtD
Rizatriptan—Pruritus—Telmisartan—coronary artery disease	5.56e-05	0.00031	CcSEcCtD
Rizatriptan—Nausea—Eplerenone—coronary artery disease	5.55e-05	0.00031	CcSEcCtD
Rizatriptan—Dizziness—Niacin—coronary artery disease	5.53e-05	0.000308	CcSEcCtD
Rizatriptan—Urticaria—Losartan—coronary artery disease	5.53e-05	0.000308	CcSEcCtD
Rizatriptan—Dry mouth—Lisinopril—coronary artery disease	5.52e-05	0.000308	CcSEcCtD
Rizatriptan—Abdominal pain—Losartan—coronary artery disease	5.5e-05	0.000307	CcSEcCtD
Rizatriptan—Body temperature increased—Losartan—coronary artery disease	5.5e-05	0.000307	CcSEcCtD
Rizatriptan—Asthenia—Captopril—coronary artery disease	5.48e-05	0.000306	CcSEcCtD
Rizatriptan—Diarrhoea—Trandolapril—coronary artery disease	5.47e-05	0.000305	CcSEcCtD
Rizatriptan—Vomiting—Valsartan—coronary artery disease	5.47e-05	0.000305	CcSEcCtD
Rizatriptan—Confusional state—Lisinopril—coronary artery disease	5.45e-05	0.000304	CcSEcCtD
Rizatriptan—Diarrhoea—Enalapril—coronary artery disease	5.45e-05	0.000304	CcSEcCtD
Rizatriptan—Dizziness—Pravastatin—coronary artery disease	5.44e-05	0.000304	CcSEcCtD
Rizatriptan—Vomiting—Olmesartan—coronary artery disease	5.44e-05	0.000303	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.43e-05	0.000303	CcSEcCtD
Rizatriptan—Rash—Valsartan—coronary artery disease	5.42e-05	0.000302	CcSEcCtD
Rizatriptan—Dermatitis—Valsartan—coronary artery disease	5.42e-05	0.000302	CcSEcCtD
Rizatriptan—Nausea—Simvastatin—coronary artery disease	5.41e-05	0.000302	CcSEcCtD
Rizatriptan—Oedema—Lisinopril—coronary artery disease	5.41e-05	0.000302	CcSEcCtD
Rizatriptan—Anaphylactic shock—Lisinopril—coronary artery disease	5.41e-05	0.000302	CcSEcCtD
Rizatriptan—Pruritus—Captopril—coronary artery disease	5.4e-05	0.000301	CcSEcCtD
Rizatriptan—Rash—Olmesartan—coronary artery disease	5.4e-05	0.000301	CcSEcCtD
Rizatriptan—Insomnia—Ramipril—coronary artery disease	5.39e-05	0.000301	CcSEcCtD
Rizatriptan—Dermatitis—Olmesartan—coronary artery disease	5.39e-05	0.000301	CcSEcCtD
Rizatriptan—Headache—Valsartan—coronary artery disease	5.39e-05	0.0003	CcSEcCtD
Rizatriptan—Diarrhoea—Telmisartan—coronary artery disease	5.37e-05	0.0003	CcSEcCtD
Rizatriptan—Headache—Olmesartan—coronary artery disease	5.36e-05	0.000299	CcSEcCtD
Rizatriptan—Paraesthesia—Ramipril—coronary artery disease	5.36e-05	0.000299	CcSEcCtD
Rizatriptan—Shock—Lisinopril—coronary artery disease	5.32e-05	0.000297	CcSEcCtD
Rizatriptan—Asthenia—Perindopril—coronary artery disease	5.32e-05	0.000297	CcSEcCtD
Rizatriptan—Dyspnoea—Ramipril—coronary artery disease	5.32e-05	0.000296	CcSEcCtD
Rizatriptan—Vomiting—Niacin—coronary artery disease	5.32e-05	0.000296	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Timolol—coronary artery disease	5.31e-05	0.000296	CcSEcCtD
Rizatriptan—Hypersensitivity—Furosemide—coronary artery disease	5.31e-05	0.000296	CcSEcCtD
Rizatriptan—Somnolence—Ramipril—coronary artery disease	5.3e-05	0.000296	CcSEcCtD
Rizatriptan—Dizziness—Trandolapril—coronary artery disease	5.29e-05	0.000295	CcSEcCtD
Rizatriptan—Tachycardia—Lisinopril—coronary artery disease	5.28e-05	0.000294	CcSEcCtD
Rizatriptan—Insomnia—Timolol—coronary artery disease	5.27e-05	0.000294	CcSEcCtD
Rizatriptan—Rash—Niacin—coronary artery disease	5.27e-05	0.000294	CcSEcCtD
Rizatriptan—Dermatitis—Niacin—coronary artery disease	5.27e-05	0.000294	CcSEcCtD
Rizatriptan—Dizziness—Enalapril—coronary artery disease	5.27e-05	0.000294	CcSEcCtD
Rizatriptan—Dyspepsia—Ramipril—coronary artery disease	5.25e-05	0.000293	CcSEcCtD
Rizatriptan—Pruritus—Perindopril—coronary artery disease	5.25e-05	0.000292	CcSEcCtD
Rizatriptan—Headache—Niacin—coronary artery disease	5.24e-05	0.000292	CcSEcCtD
Rizatriptan—Paraesthesia—Timolol—coronary artery disease	5.24e-05	0.000292	CcSEcCtD
Rizatriptan—Vomiting—Pravastatin—coronary artery disease	5.23e-05	0.000292	CcSEcCtD
Rizatriptan—Hyperhidrosis—Lisinopril—coronary artery disease	5.23e-05	0.000292	CcSEcCtD
Rizatriptan—Diarrhoea—Captopril—coronary artery disease	5.23e-05	0.000291	CcSEcCtD
Rizatriptan—Dyspnoea—Timolol—coronary artery disease	5.2e-05	0.00029	CcSEcCtD
Rizatriptan—Dizziness—Telmisartan—coronary artery disease	5.19e-05	0.00029	CcSEcCtD
Rizatriptan—Rash—Pravastatin—coronary artery disease	5.19e-05	0.000289	CcSEcCtD
Rizatriptan—Dermatitis—Pravastatin—coronary artery disease	5.19e-05	0.000289	CcSEcCtD
Rizatriptan—Decreased appetite—Ramipril—coronary artery disease	5.18e-05	0.000289	CcSEcCtD
Rizatriptan—Somnolence—Timolol—coronary artery disease	5.18e-05	0.000289	CcSEcCtD
Rizatriptan—Asthenia—Furosemide—coronary artery disease	5.17e-05	0.000288	CcSEcCtD
Rizatriptan—Headache—Pravastatin—coronary artery disease	5.16e-05	0.000288	CcSEcCtD
Rizatriptan—Anorexia—Lisinopril—coronary artery disease	5.16e-05	0.000287	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Ramipril—coronary artery disease	5.15e-05	0.000287	CcSEcCtD
Rizatriptan—Fatigue—Ramipril—coronary artery disease	5.14e-05	0.000287	CcSEcCtD
Rizatriptan—Dyspepsia—Timolol—coronary artery disease	5.13e-05	0.000286	CcSEcCtD
Rizatriptan—Hypersensitivity—Losartan—coronary artery disease	5.12e-05	0.000286	CcSEcCtD
Rizatriptan—Nausea—Valsartan—coronary artery disease	5.11e-05	0.000285	CcSEcCtD
Rizatriptan—Pruritus—Furosemide—coronary artery disease	5.1e-05	0.000284	CcSEcCtD
Rizatriptan—Constipation—Ramipril—coronary artery disease	5.1e-05	0.000284	CcSEcCtD
Rizatriptan—Nausea—Olmesartan—coronary artery disease	5.08e-05	0.000283	CcSEcCtD
Rizatriptan—Vomiting—Trandolapril—coronary artery disease	5.08e-05	0.000283	CcSEcCtD
Rizatriptan—Diarrhoea—Perindopril—coronary artery disease	5.07e-05	0.000283	CcSEcCtD
Rizatriptan—Decreased appetite—Timolol—coronary artery disease	5.07e-05	0.000283	CcSEcCtD
Rizatriptan—Vomiting—Enalapril—coronary artery disease	5.06e-05	0.000282	CcSEcCtD
Rizatriptan—Dizziness—Captopril—coronary artery disease	5.05e-05	0.000282	CcSEcCtD
Rizatriptan—Rash—Trandolapril—coronary artery disease	5.04e-05	0.000281	CcSEcCtD
Rizatriptan—Dermatitis—Trandolapril—coronary artery disease	5.04e-05	0.000281	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Timolol—coronary artery disease	5.03e-05	0.000281	CcSEcCtD
Rizatriptan—Fatigue—Timolol—coronary artery disease	5.03e-05	0.00028	CcSEcCtD
Rizatriptan—Rash—Enalapril—coronary artery disease	5.02e-05	0.00028	CcSEcCtD
Rizatriptan—Dermatitis—Enalapril—coronary artery disease	5.02e-05	0.00028	CcSEcCtD
Rizatriptan—Headache—Trandolapril—coronary artery disease	5.01e-05	0.000279	CcSEcCtD
Rizatriptan—Vomiting—Telmisartan—coronary artery disease	4.99e-05	0.000278	CcSEcCtD
Rizatriptan—Asthenia—Losartan—coronary artery disease	4.99e-05	0.000278	CcSEcCtD
Rizatriptan—Headache—Enalapril—coronary artery disease	4.99e-05	0.000278	CcSEcCtD
Rizatriptan—Pain—Timolol—coronary artery disease	4.99e-05	0.000278	CcSEcCtD
Rizatriptan—Nausea—Niacin—coronary artery disease	4.97e-05	0.000277	CcSEcCtD
Rizatriptan—Rash—Telmisartan—coronary artery disease	4.95e-05	0.000276	CcSEcCtD
Rizatriptan—Dermatitis—Telmisartan—coronary artery disease	4.95e-05	0.000276	CcSEcCtD
Rizatriptan—Diarrhoea—Furosemide—coronary artery disease	4.93e-05	0.000275	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.93e-05	0.000275	CcSEcCtD
Rizatriptan—Pruritus—Losartan—coronary artery disease	4.92e-05	0.000274	CcSEcCtD
Rizatriptan—Headache—Telmisartan—coronary artery disease	4.92e-05	0.000274	CcSEcCtD
Rizatriptan—Feeling abnormal—Ramipril—coronary artery disease	4.91e-05	0.000274	CcSEcCtD
Rizatriptan—Dizziness—Perindopril—coronary artery disease	4.9e-05	0.000273	CcSEcCtD
Rizatriptan—Insomnia—Lisinopril—coronary artery disease	4.89e-05	0.000273	CcSEcCtD
Rizatriptan—Nausea—Pravastatin—coronary artery disease	4.89e-05	0.000273	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Ramipril—coronary artery disease	4.88e-05	0.000272	CcSEcCtD
Rizatriptan—Paraesthesia—Lisinopril—coronary artery disease	4.86e-05	0.000271	CcSEcCtD
Rizatriptan—Vomiting—Captopril—coronary artery disease	4.86e-05	0.000271	CcSEcCtD
Rizatriptan—Dyspnoea—Lisinopril—coronary artery disease	4.82e-05	0.000269	CcSEcCtD
Rizatriptan—Rash—Captopril—coronary artery disease	4.82e-05	0.000268	CcSEcCtD
Rizatriptan—Dermatitis—Captopril—coronary artery disease	4.81e-05	0.000268	CcSEcCtD
Rizatriptan—Somnolence—Lisinopril—coronary artery disease	4.81e-05	0.000268	CcSEcCtD
Rizatriptan—Feeling abnormal—Timolol—coronary artery disease	4.8e-05	0.000268	CcSEcCtD
Rizatriptan—Headache—Captopril—coronary artery disease	4.78e-05	0.000267	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Timolol—coronary artery disease	4.77e-05	0.000266	CcSEcCtD
Rizatriptan—Dizziness—Furosemide—coronary artery disease	4.77e-05	0.000266	CcSEcCtD
Rizatriptan—Dyspepsia—Lisinopril—coronary artery disease	4.76e-05	0.000265	CcSEcCtD
Rizatriptan—Diarrhoea—Losartan—coronary artery disease	4.76e-05	0.000265	CcSEcCtD
Rizatriptan—Nausea—Trandolapril—coronary artery disease	4.75e-05	0.000265	CcSEcCtD
Rizatriptan—Urticaria—Ramipril—coronary artery disease	4.74e-05	0.000264	CcSEcCtD
Rizatriptan—Nausea—Enalapril—coronary artery disease	4.73e-05	0.000264	CcSEcCtD
Rizatriptan—Vomiting—Perindopril—coronary artery disease	4.71e-05	0.000263	CcSEcCtD
Rizatriptan—Body temperature increased—Ramipril—coronary artery disease	4.71e-05	0.000263	CcSEcCtD
Rizatriptan—Abdominal pain—Ramipril—coronary artery disease	4.71e-05	0.000263	CcSEcCtD
Rizatriptan—Decreased appetite—Lisinopril—coronary artery disease	4.7e-05	0.000262	CcSEcCtD
Rizatriptan—Rash—Perindopril—coronary artery disease	4.68e-05	0.000261	CcSEcCtD
Rizatriptan—Dermatitis—Perindopril—coronary artery disease	4.67e-05	0.00026	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.67e-05	0.00026	CcSEcCtD
Rizatriptan—Nausea—Telmisartan—coronary artery disease	4.67e-05	0.00026	CcSEcCtD
Rizatriptan—Fatigue—Lisinopril—coronary artery disease	4.66e-05	0.00026	CcSEcCtD
Rizatriptan—Headache—Perindopril—coronary artery disease	4.65e-05	0.000259	CcSEcCtD
Rizatriptan—Urticaria—Timolol—coronary artery disease	4.63e-05	0.000258	CcSEcCtD
Rizatriptan—Pain—Lisinopril—coronary artery disease	4.63e-05	0.000258	CcSEcCtD
Rizatriptan—Constipation—Lisinopril—coronary artery disease	4.63e-05	0.000258	CcSEcCtD
Rizatriptan—Body temperature increased—Timolol—coronary artery disease	4.61e-05	0.000257	CcSEcCtD
Rizatriptan—Abdominal pain—Timolol—coronary artery disease	4.61e-05	0.000257	CcSEcCtD
Rizatriptan—Dizziness—Losartan—coronary artery disease	4.6e-05	0.000256	CcSEcCtD
Rizatriptan—Vomiting—Furosemide—coronary artery disease	4.58e-05	0.000256	CcSEcCtD
Rizatriptan—Rash—Furosemide—coronary artery disease	4.55e-05	0.000253	CcSEcCtD
Rizatriptan—Dermatitis—Furosemide—coronary artery disease	4.54e-05	0.000253	CcSEcCtD
Rizatriptan—Nausea—Captopril—coronary artery disease	4.54e-05	0.000253	CcSEcCtD
Rizatriptan—Headache—Furosemide—coronary artery disease	4.52e-05	0.000252	CcSEcCtD
Rizatriptan—Feeling abnormal—Lisinopril—coronary artery disease	4.46e-05	0.000248	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Lisinopril—coronary artery disease	4.42e-05	0.000247	CcSEcCtD
Rizatriptan—Vomiting—Losartan—coronary artery disease	4.42e-05	0.000247	CcSEcCtD
Rizatriptan—Nausea—Perindopril—coronary artery disease	4.4e-05	0.000246	CcSEcCtD
Rizatriptan—Hypersensitivity—Ramipril—coronary artery disease	4.39e-05	0.000245	CcSEcCtD
Rizatriptan—Rash—Losartan—coronary artery disease	4.39e-05	0.000245	CcSEcCtD
Rizatriptan—Dermatitis—Losartan—coronary artery disease	4.38e-05	0.000244	CcSEcCtD
Rizatriptan—Headache—Losartan—coronary artery disease	4.36e-05	0.000243	CcSEcCtD
Rizatriptan—Urticaria—Lisinopril—coronary artery disease	4.3e-05	0.00024	CcSEcCtD
Rizatriptan—Hypersensitivity—Timolol—coronary artery disease	4.3e-05	0.000239	CcSEcCtD
Rizatriptan—Nausea—Furosemide—coronary artery disease	4.28e-05	0.000239	CcSEcCtD
Rizatriptan—Asthenia—Ramipril—coronary artery disease	4.28e-05	0.000239	CcSEcCtD
Rizatriptan—Body temperature increased—Lisinopril—coronary artery disease	4.28e-05	0.000238	CcSEcCtD
Rizatriptan—Abdominal pain—Lisinopril—coronary artery disease	4.28e-05	0.000238	CcSEcCtD
Rizatriptan—Pruritus—Ramipril—coronary artery disease	4.22e-05	0.000235	CcSEcCtD
Rizatriptan—Asthenia—Timolol—coronary artery disease	4.18e-05	0.000233	CcSEcCtD
Rizatriptan—Nausea—Losartan—coronary artery disease	4.13e-05	0.00023	CcSEcCtD
Rizatriptan—Pruritus—Timolol—coronary artery disease	4.12e-05	0.00023	CcSEcCtD
Rizatriptan—Diarrhoea—Ramipril—coronary artery disease	4.08e-05	0.000228	CcSEcCtD
Rizatriptan—Diarrhoea—Timolol—coronary artery disease	3.99e-05	0.000222	CcSEcCtD
Rizatriptan—Hypersensitivity—Lisinopril—coronary artery disease	3.98e-05	0.000222	CcSEcCtD
Rizatriptan—Dizziness—Ramipril—coronary artery disease	3.94e-05	0.00022	CcSEcCtD
Rizatriptan—Asthenia—Lisinopril—coronary artery disease	3.88e-05	0.000216	CcSEcCtD
Rizatriptan—Dizziness—Timolol—coronary artery disease	3.86e-05	0.000215	CcSEcCtD
Rizatriptan—Pruritus—Lisinopril—coronary artery disease	3.83e-05	0.000213	CcSEcCtD
Rizatriptan—Vomiting—Ramipril—coronary artery disease	3.79e-05	0.000211	CcSEcCtD
Rizatriptan—Rash—Ramipril—coronary artery disease	3.76e-05	0.00021	CcSEcCtD
Rizatriptan—Dermatitis—Ramipril—coronary artery disease	3.76e-05	0.000209	CcSEcCtD
Rizatriptan—Headache—Ramipril—coronary artery disease	3.74e-05	0.000208	CcSEcCtD
Rizatriptan—Vomiting—Timolol—coronary artery disease	3.71e-05	0.000207	CcSEcCtD
Rizatriptan—Diarrhoea—Lisinopril—coronary artery disease	3.7e-05	0.000206	CcSEcCtD
Rizatriptan—Rash—Timolol—coronary artery disease	3.68e-05	0.000205	CcSEcCtD
Rizatriptan—Dermatitis—Timolol—coronary artery disease	3.67e-05	0.000205	CcSEcCtD
Rizatriptan—Headache—Timolol—coronary artery disease	3.65e-05	0.000204	CcSEcCtD
Rizatriptan—Dizziness—Lisinopril—coronary artery disease	3.58e-05	0.000199	CcSEcCtD
Rizatriptan—Nausea—Ramipril—coronary artery disease	3.54e-05	0.000198	CcSEcCtD
Rizatriptan—Nausea—Timolol—coronary artery disease	3.46e-05	0.000193	CcSEcCtD
Rizatriptan—Vomiting—Lisinopril—coronary artery disease	3.44e-05	0.000192	CcSEcCtD
Rizatriptan—Rash—Lisinopril—coronary artery disease	3.41e-05	0.00019	CcSEcCtD
Rizatriptan—Dermatitis—Lisinopril—coronary artery disease	3.41e-05	0.00019	CcSEcCtD
Rizatriptan—Headache—Lisinopril—coronary artery disease	3.39e-05	0.000189	CcSEcCtD
Rizatriptan—Nausea—Lisinopril—coronary artery disease	3.21e-05	0.000179	CcSEcCtD
Rizatriptan—HTR1A—Signaling by GPCR—CREB1—coronary artery disease	6.27e-06	6.95e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AGTR1—coronary artery disease	6.25e-06	6.94e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PRKCD—coronary artery disease	6.22e-06	6.9e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HTR2A—coronary artery disease	6.22e-06	6.9e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—C3—coronary artery disease	6.21e-06	6.89e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AGT—coronary artery disease	6.19e-06	6.87e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC22A3—coronary artery disease	6.18e-06	6.85e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL2—coronary artery disease	6.14e-06	6.8e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6R—coronary artery disease	6.12e-06	6.78e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL10—coronary artery disease	6.11e-06	6.78e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PLG—coronary artery disease	6.1e-06	6.76e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HTR2A—coronary artery disease	6.09e-06	6.75e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ARNTL—coronary artery disease	6.09e-06	6.75e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HADH—coronary artery disease	6.09e-06	6.75e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—C3—coronary artery disease	6.08e-06	6.74e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOE—coronary artery disease	6.07e-06	6.73e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL8—coronary artery disease	6.01e-06	6.66e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOA1—coronary artery disease	6e-06	6.65e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	5.99e-06	6.65e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRB2—coronary artery disease	5.93e-06	6.58e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HIF1A—coronary artery disease	5.92e-06	6.57e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AGT—coronary artery disease	5.9e-06	6.54e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PRKCE—coronary artery disease	5.86e-06	6.5e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—JAK2—coronary artery disease	5.85e-06	6.49e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	5.85e-06	6.48e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SOCS1—coronary artery disease	5.84e-06	6.48e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—S100B—coronary artery disease	5.83e-06	6.46e-05	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AKT1—coronary artery disease	5.8e-06	6.44e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HIF1A—coronary artery disease	5.8e-06	6.43e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOE—coronary artery disease	5.78e-06	6.41e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LEP—coronary artery disease	5.78e-06	6.41e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AGT—coronary artery disease	5.78e-06	6.41e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SOCS3—coronary artery disease	5.77e-06	6.4e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPX2—coronary artery disease	5.77e-06	6.4e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	5.77e-06	6.4e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOA2—coronary artery disease	5.77e-06	6.4e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CASP3—coronary artery disease	5.75e-06	6.38e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOA1—coronary artery disease	5.72e-06	6.34e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—coronary artery disease	5.71e-06	6.33e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KITLG—coronary artery disease	5.7e-06	6.32e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFBR2—coronary artery disease	5.7e-06	6.32e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCG5—coronary artery disease	5.7e-06	6.32e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SULT1A1—coronary artery disease	5.7e-06	6.32e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HK1—coronary artery disease	5.7e-06	6.32e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPX4—coronary artery disease	5.7e-06	6.32e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	5.7e-06	6.32e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KDR—coronary artery disease	5.66e-06	6.28e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LEP—coronary artery disease	5.66e-06	6.28e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOE—coronary artery disease	5.66e-06	6.28e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HADHA—coronary artery disease	5.63e-06	6.25e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK14—coronary artery disease	5.63e-06	6.24e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCND1—coronary artery disease	5.6e-06	6.21e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOA1—coronary artery disease	5.6e-06	6.21e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STAT5A—coronary artery disease	5.57e-06	6.18e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP3—coronary artery disease	5.57e-06	6.18e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTA1—coronary artery disease	5.57e-06	6.17e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KDR—coronary artery disease	5.55e-06	6.15e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ESR1—coronary artery disease	5.52e-06	6.12e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK14—coronary artery disease	5.51e-06	6.11e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LPA—coronary artery disease	5.51e-06	6.11e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—F2—coronary artery disease	5.45e-06	6.05e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FN1—coronary artery disease	5.45e-06	6.05e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—coronary artery disease	5.43e-06	6.03e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6ST—coronary artery disease	5.43e-06	6.02e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ESR1—coronary artery disease	5.4e-06	5.99e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOB—coronary artery disease	5.39e-06	5.97e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NFKBIA—coronary artery disease	5.39e-06	5.97e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL8—coronary artery disease	5.34e-06	5.92e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FN1—coronary artery disease	5.34e-06	5.92e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—F2—coronary artery disease	5.34e-06	5.92e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLCB3—coronary artery disease	5.33e-06	5.91e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6ST—coronary artery disease	5.32e-06	5.9e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—JAK2—coronary artery disease	5.32e-06	5.89e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EDN1—coronary artery disease	5.3e-06	5.88e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARG—coronary artery disease	5.28e-06	5.86e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOA5—coronary artery disease	5.28e-06	5.85e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NFKBIA—coronary artery disease	5.28e-06	5.85e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT1—coronary artery disease	5.27e-06	5.84e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL5—coronary artery disease	5.26e-06	5.83e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KIT—coronary artery disease	5.22e-06	5.79e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—POMC—coronary artery disease	5.21e-06	5.78e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF1—coronary artery disease	5.18e-06	5.75e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CSF2—coronary artery disease	5.18e-06	5.75e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—P4HB—coronary artery disease	5.18e-06	5.74e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LPL—coronary artery disease	5.14e-06	5.7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	5.13e-06	5.69e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KIT—coronary artery disease	5.11e-06	5.66e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RPS6KB1—coronary artery disease	5.1e-06	5.65e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MEF2C—coronary artery disease	5.1e-06	5.65e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	5.08e-06	5.63e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	5.02e-06	5.57e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GSK3B—coronary artery disease	5.01e-06	5.55e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ITGB3—coronary artery disease	4.97e-06	5.51e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	4.97e-06	5.51e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—POMC—coronary artery disease	4.97e-06	5.51e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CREB1—coronary artery disease	4.97e-06	5.51e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GSK3B—coronary artery disease	4.9e-06	5.44e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—coronary artery disease	4.88e-06	5.41e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—POMC—coronary artery disease	4.86e-06	5.39e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CREB1—coronary artery disease	4.86e-06	5.39e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL2—coronary artery disease	4.86e-06	5.39e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL8—coronary artery disease	4.85e-06	5.38e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6R—coronary artery disease	4.84e-06	5.37e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PPP2CA—coronary artery disease	4.83e-06	5.35e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—VCAN—coronary artery disease	4.79e-06	5.31e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1—coronary artery disease	4.78e-06	5.3e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL2—coronary artery disease	4.76e-06	5.28e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—MAPK1—coronary artery disease	4.75e-06	5.27e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALDOA—coronary artery disease	4.75e-06	5.27e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALB—coronary artery disease	4.75e-06	5.27e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6R—coronary artery disease	4.74e-06	5.26e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PRKCD—coronary artery disease	4.74e-06	5.26e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1—coronary artery disease	4.68e-06	5.19e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—MAPK1—coronary artery disease	4.66e-06	5.16e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HTR2A—coronary artery disease	4.64e-06	5.14e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—C3—coronary artery disease	4.63e-06	5.14e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—DCN—coronary artery disease	4.61e-06	5.12e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NOS3—coronary artery disease	4.55e-06	5.04e-05	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CA—coronary artery disease	4.54e-06	5.04e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SERPINE1—coronary artery disease	4.54e-06	5.03e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALDH2—coronary artery disease	4.49e-06	4.98e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFB1—coronary artery disease	4.48e-06	4.97e-05	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CA—coronary artery disease	4.45e-06	4.93e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SERPINE1—coronary artery disease	4.44e-06	4.93e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HIF1A—coronary artery disease	4.42e-06	4.9e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AGT—coronary artery disease	4.4e-06	4.88e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK1—coronary artery disease	4.39e-06	4.87e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGF2—coronary artery disease	4.39e-06	4.87e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.38e-06	4.85e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HBA1—coronary artery disease	4.37e-06	4.85e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LIPC—coronary artery disease	4.37e-06	4.85e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2C19—coronary artery disease	4.37e-06	4.85e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	4.37e-06	4.85e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOC3—coronary artery disease	4.35e-06	4.82e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOS3—coronary artery disease	4.33e-06	4.8e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LDLR—coronary artery disease	4.32e-06	4.79e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.32e-06	4.79e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LEP—coronary artery disease	4.31e-06	4.78e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOE—coronary artery disease	4.31e-06	4.78e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGF2—coronary artery disease	4.3e-06	4.77e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC9A1—coronary artery disease	4.27e-06	4.73e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTT1—coronary artery disease	4.27e-06	4.73e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOA1—coronary artery disease	4.26e-06	4.73e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOS3—coronary artery disease	4.24e-06	4.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KDR—coronary artery disease	4.22e-06	4.68e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GCLC—coronary artery disease	4.22e-06	4.68e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CETP—coronary artery disease	4.22e-06	4.68e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—JAK2—coronary artery disease	4.21e-06	4.67e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK14—coronary artery disease	4.2e-06	4.65e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SDC1—coronary artery disease	4.17e-06	4.63e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—coronary artery disease	4.16e-06	4.61e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CA—coronary artery disease	4.13e-06	4.57e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—JAK2—coronary artery disease	4.12e-06	4.57e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ESR1—coronary artery disease	4.12e-06	4.57e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—F2—coronary artery disease	4.07e-06	4.51e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FN1—coronary artery disease	4.07e-06	4.51e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6ST—coronary artery disease	4.05e-06	4.49e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CA—coronary artery disease	4.04e-06	4.48e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NFKBIA—coronary artery disease	4.02e-06	4.46e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PSMB5—coronary artery disease	3.94e-06	4.37e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PSMA6—coronary artery disease	3.94e-06	4.37e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.94e-06	4.36e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KIT—coronary artery disease	3.89e-06	4.32e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CTGF—coronary artery disease	3.85e-06	4.27e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL8—coronary artery disease	3.84e-06	4.26e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMGCR—coronary artery disease	3.82e-06	4.23e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GOT2—coronary artery disease	3.82e-06	4.23e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CA—coronary artery disease	3.81e-06	4.23e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL8—coronary artery disease	3.76e-06	4.17e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	3.73e-06	4.14e-05	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—coronary artery disease	3.71e-06	4.12e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—POMC—coronary artery disease	3.7e-06	4.11e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CREB1—coronary artery disease	3.7e-06	4.11e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—coronary artery disease	3.68e-06	4.08e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—coronary artery disease	3.65e-06	4.05e-05	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—coronary artery disease	3.63e-06	4.03e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL2—coronary artery disease	3.62e-06	4.02e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6R—coronary artery disease	3.61e-06	4.01e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—coronary artery disease	3.6e-06	3.99e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCND1—coronary artery disease	3.58e-06	3.97e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—coronary artery disease	3.58e-06	3.97e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1—coronary artery disease	3.56e-06	3.95e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	3.55e-06	3.93e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLCB1—coronary artery disease	3.51e-06	3.89e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCND1—coronary artery disease	3.5e-06	3.89e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—coronary artery disease	3.48e-06	3.85e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.44e-06	3.82e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—coronary artery disease	3.4e-06	3.77e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCA1—coronary artery disease	3.4e-06	3.77e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	3.39e-06	3.76e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	3.38e-06	3.75e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—coronary artery disease	3.37e-06	3.74e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—coronary artery disease	3.37e-06	3.74e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—coronary artery disease	3.3e-06	3.66e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GGT1—coronary artery disease	3.29e-06	3.65e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GOT1—coronary artery disease	3.29e-06	3.65e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF2—coronary artery disease	3.28e-06	3.63e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOS3—coronary artery disease	3.23e-06	3.58e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JAK2—coronary artery disease	3.14e-06	3.48e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—coronary artery disease	3.12e-06	3.46e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—coronary artery disease	3.11e-06	3.45e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.08e-06	3.41e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	3.06e-06	3.39e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.96e-06	3.28e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.93e-06	3.25e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.92e-06	3.24e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CAT—coronary artery disease	2.88e-06	3.19e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	2.87e-06	3.18e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	2.86e-06	3.18e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	2.81e-06	3.11e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	2.8e-06	3.11e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOB—coronary artery disease	2.8e-06	3.1e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	2.77e-06	3.07e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	2.75e-06	3.05e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—coronary artery disease	2.74e-06	3.04e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—coronary artery disease	2.73e-06	3.02e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.72e-06	3.02e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCND1—coronary artery disease	2.67e-06	2.96e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LPL—coronary artery disease	2.67e-06	2.96e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPX1—coronary artery disease	2.6e-06	2.89e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—coronary artery disease	2.59e-06	2.87e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CA—coronary artery disease	2.56e-06	2.84e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CD36—coronary artery disease	2.54e-06	2.81e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	2.51e-06	2.79e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.5e-06	2.78e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	2.44e-06	2.7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.4e-06	2.67e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	2.39e-06	2.65e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	2.33e-06	2.58e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AGT—coronary artery disease	2.28e-06	2.53e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOE—coronary artery disease	2.24e-06	2.48e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOA1—coronary artery disease	2.21e-06	2.45e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—coronary artery disease	2.16e-06	2.39e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	2.14e-06	2.37e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.12e-06	2.35e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—coronary artery disease	2.11e-06	2.34e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	2.1e-06	2.32e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—coronary artery disease	2.09e-06	2.32e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—coronary artery disease	1.99e-06	2.21e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—coronary artery disease	1.95e-06	2.16e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARG—coronary artery disease	1.95e-06	2.16e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—POMC—coronary artery disease	1.92e-06	2.13e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	1.82e-06	2.02e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALB—coronary artery disease	1.75e-06	1.94e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NOS3—coronary artery disease	1.68e-06	1.86e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—coronary artery disease	1.61e-06	1.78e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.53e-06	1.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—coronary artery disease	1.49e-06	1.65e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CA—coronary artery disease	9.43e-07	1.05e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—coronary artery disease	7.71e-07	8.54e-06	CbGpPWpGaD
